recent articles
Artificial intelligence-powered predictive analytics tools can improve hospital operations by optimizing capacity demands, alerting care teams of patients who may be at risk for adverse events and anticipating supply shortages, among other...
Two of Moderna’s founders, and one investor, are among 44 new billionaires on the Forbes 400 list this year At least three people with a stake in the coronavirus vaccine race have just made a list of the top 400 richest people in...
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization...
CAMBRIDGE, Mass. — At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize...
Science visited Moderna in 2017 for an early look at its innovative RNA-based technology for drugs and vaccines. *Update, 16 November, 9:10 a.m.: Moderna announced today that its experimental mRNA vaccine for COVID-19 achieved 94.5% protective...
JOIN THE LIVE WEBINAR Date and time : June 2, 2021 at 11:00am (EDT)/5:00pm (CET) Exploiting digital histology approaches to probe the pathophysiology of SARS-CoV-2 infection Register Now COVID-19 is a complex multi-phase disease. In most...